The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer

DOI: 10.1177/1758835919870360

Keywords: anti-PD-1, anti-PD-L1, chemotherapy, combination immunotherapy, immunotherapy, non-small cell lung cancer (NSCLC)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text